BerGenBio - Helping the World`s leading Pharmaceutical Companies Make Drug Development More Cost Efficient
Research and Development Biotech Pharmaceutical Company operationg as a fee for service CRO and developing a pipeline of targets and theraputics.
BergenBio uses its`s proprietary RNAi technologies
16.11.09: AACR-NCI-EORTC Molecular targets and Cancer Therapeutics, Boston, MA.
17.09.09: BergenBio present at the 6th anual RNAi Europe conference, Berlin.
02.09.09: Present at European Cancer Cluster Partnering in Toulouse, France.
07.08.09: BerGenBio receives Grand from Innovation Norway
02.07.09: CellSellect RNAi patent published.
24.06.09: BergenBio at EPIC Biotech conference London.
29.04.09: BergenBio AS at BioAtlanta
2009.
05.05.09: Joins Oslo Cancer Cluster
29.04.09: CellSelectRNAi™patent
filing.
29.04.09: BergenBio signs a $2m
contract with bluechip.
29.04.09: BergenBio Identifies it`s first novel target.